metformin has been researched along with Action Myoclonus-Renal Failure Syndrome in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin was titrated to a mean maintenance dose of 1167 mg/day (range: 500-2000 mg)." | 1.51 | Treatment with metformin in twelve patients with Lafora disease. ( Avolio, C; Bisulli, F; Canafoglia, L; d'Orsi, G; Freri, E; Licchetta, L; Martino, T; Michelucci, R; Mostacci, B; Muccioli, L; Pondrelli, F; Riguzzi, P; Tinuper, P, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisulli, F | 1 |
| Muccioli, L | 1 |
| d'Orsi, G | 1 |
| Canafoglia, L | 1 |
| Freri, E | 1 |
| Licchetta, L | 1 |
| Mostacci, B | 1 |
| Riguzzi, P | 1 |
| Pondrelli, F | 1 |
| Avolio, C | 1 |
| Martino, T | 1 |
| Michelucci, R | 1 |
| Tinuper, P | 1 |
1 other study available for metformin and Action Myoclonus-Renal Failure Syndrome
| Article | Year |
|---|---|
Treatment with metformin in twelve patients with Lafora disease.
Topics: Adolescent; Animals; Disease Models, Animal; Female; Humans; Lafora Disease; Male; Metformin; Mutati | 2019 |